Header Logo

Connection

Beth Resman-Targoff to Evidence-Based Medicine

This is a "connection" page, showing publications Beth Resman-Targoff has written about Evidence-Based Medicine.
Connection Strength

0.060
  1. Celecoxib versus a non-selective NSAID plus proton-pump inhibitor: what are the considerations?. J Pain Palliat Care Pharmacother. 2006; 20(4):11-32.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.